Abacipharm Corporation | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (410) 417-5545 | |||
![]() |
sales@abacipharm.com | |||
Chemical manufacturer | ||||
Achemica | Switzerland | Inquire | ||
---|---|---|---|---|
![]() |
+41 (24) 466-2929 | |||
![]() |
contact@achemica.com | |||
Chemical manufacturer since 2010 | ||||
ChemPacific Corp | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (410) 633-5771 | |||
![]() |
sales@chempacific.com | |||
Chemical manufacturer since 1995 | ||||
International Laboratory Limited | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (650) 278-9963 | |||
![]() |
admin@intlab.org | |||
Chemical manufacturer since 2002 | ||||
Matrix Scientific Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (803) 788-9494 | |||
![]() |
sales@matrixscientific.com | |||
Chemical manufacturer | ||||
Otava Ltd. | Ukraine | Inquire | ||
---|---|---|---|---|
![]() |
+380 (44) 522-2458 | |||
![]() |
order@otavachemicals.com | |||
Chemical manufacturer since 1997 | ||||
SynQuest Labs, Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (386) 462-0788 | |||
![]() |
info@synquestlabs.com | |||
Chemical manufacturer | ||||
ZereneX Molecular Ltd. | UK | Inquire | ||
---|---|---|---|---|
![]() |
+44 (1204) 527-700 | |||
![]() |
sales@zerenex-molecular.com | |||
Chemical manufacturer | ||||
Name | (4-Bromo-2-Thienyl)Acetonitrile |
---|---|
Synonyms | (4-Bromo-thiophen-2-yl)-acetonitrile; 2-(4-bromothiophen-2-yl)acetonitrile; MFCD09475422 |
Molecular Structure | ![]() |
Molecular Formula | C6H4BrNS |
Molecular Weight | 202.07 |
CAS Registry Number | 160005-43-6 |
SMILES | N#CCc1cc(Br)cs1 |
InChI | 1S/C6H4BrNS/c7-5-3-6(1-2-8)9-4-5/h3-4H,1H2 |
InChIKey | PBIOBPCDJCIIOW-UHFFFAOYSA-N |
Density | 1.666g/cm3 (Cal.) |
---|---|
Boiling point | 289.307°C at 760 mmHg (Cal.) |
Flash point | 128.769°C (Cal.) |
Refractive index | 1.605 (Cal.) |
Safety Description | IRRITANT, IRRITANT-HARMFUL |
---|---|
SDS | Available |
Market Analysis Reports |
List of Reports Available for (4-Bromo-2-Thienyl)Acetonitrile |